by | Jan 22, 2026 | Adams, Lucas, Diamond, Michael, Fremont, Daved, Raju, Saravanan
— Published date: 1/14/2026
Value Proposition: Method and composition to potently neutralize EEEV infection.
Technology Description
Researchers at Washington University in St. Louis have developed very low-density lipoprotein receptor (VLDLR) soluble decoy receptors with potent inhibitory acti…
by | Jan 15, 2026 | Brunner, Peter, Tan, Gansheng
— Published date: 1/16/2026
Value Proposition: Fully automatic and robust process for localization of rigid or semi-rigid Intracerebral electrodes in neurosurgical patients.
Technology Description
Researchers at Washington University in St. Louis have developed a fully automated, rapid imagin…
by | Jan 5, 2026 | Dai, Yifan, Pappu, Rohit
— Published date: 1/6/2025
Value Proposition: Directed evolution of synthetic intrinsically disordered proteins for condensate editing.
Technology Description
Researchers at Washington University in St. Louis have developed a directed evolution method and selection strategies to enable the evolut…
by | Sep 17, 2025 | Alexander-Brett, Jennifer, Brett, Thomas, Greven, Jessica, Wydra, Joshua
— Published date: 9/18/2025
Value Proposition: Variant protein library that can map ligand binding.
Technology Description
Researchers at Washington University in St. Louis have developed a TREM2 variant protein library that can be used to map interactions with ligands to guide development of the…
by | May 14, 2025 | Oh, Youngmi, Yoo, Andrew
— Published Date: 5/14/2025
Value Proposition: Novel antisense oligonucleotide (ASO) directly targeting a microRNA-mediated mechanism responsible for autophagy reduction and neurodegeneration in Huntington’s disease (HD) improving patient outcomes in pre-HD subjects.
Technology Description
R…